SEEL News and Press, Seelos Therapeutics Inc. From 05/28/24

A recently conducted analysis has determined that people who had used psychedelics at some point in their lives experienced less psychological distress. The analysis also revealed that this link was highest in single people and significantly reduced in individuals who were married, divorced o...

2024-05-17 04:24:16 ET More on Seelos Therapeutics Seelos drops as lead drug fails in ALS trial Seelos Therapeutics files for 3.4M shares secondary offering Financial information for Seelos Therapeutics Read the full article on Seeking Alpha For furth...

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules PR Newswire NEW YORK , May 16, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the...

2024-05-16 10:00:47 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...

2024-05-16 09:02:04 ET Seelos Therapeutics Inc (SEEL) announced stock split at a ratio of 1-for-8 on 2024-05-16 ... Full story available on KlickAnalytics.com

2024-05-14 13:53:36 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Seelos Therapeutics (NASDAQ: SEEL ) just reported results for the first quarter of 2024. Seelos Therapeutics reported earnings per share of -20 cents. This was above the a...

Seelos Therapeutics Announces 1-for-8 Reverse Stock Split PR Newswire NEW YORK , May 14, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies ...

A survey conducted by YouGov has found that a majority of U.S. citizens have used marijuana before, and most of them revealed that the experience was a positive one. This survey also discovered that 20% of Americans have also tried “magic mushrooms” (psilocybin mushrooms), and an ...

The U.S. Drug Enforcement Administration (DEA) is claiming that a federal law that affords severely ill individuals the right to try investigational medications doesn’t apply to drugs classified under the Controlled Substances Act. This is in response to a lawsuit filed by a doctor in ...

2024-04-29 13:37:07 ET More on psychedelic drug developers Psychedelic drugs market to break $7B in 2029 led by these 3 meds Cybin spikes after FDA breakthrough tag for psychedelic therapy Psychedelic stocks gain after FDA priority review for MDMA therapy ...